Moreover, miR-124, which is transported by MSC-EVs, exerts an inhibitory effect on glioblastoma (GBM) migration by targeting CDK6, while also enhancing the susceptibility of GBM cells to temozolomide (TMZ) therapy105. Here, CDK6 is linked to glioblastoma.